SOX2 and multiple sclerosis: In the study conducted by Farhangi et al. in 2019, they demonstrated that Sox2 could facilitate the conversion of astrocytes into oligodendrocyte precursor cells, ultimately leading to myelinating cells (PDGFRa+) in a multiple sclerosis model [28].